How to predict the sensitivity of drug therapy to colorectal cancer

摘要

The present invention relates to a method for predicting responsiveness to cancer drug therapy for colorectal cancer. More specifically, it is a method for predicting responsiveness to cancer drug therapy in patients with colorectal cancer, and the DNA methylation level in a test subject's colorectal cancer tissue, colorectal cancer cells, or a sample containing DNA derived from colorectal cancer cells. The present invention relates to a method of analyzing and determining cancer drug therapy response of the subject based on the DNA methylation level.